NASDAQ:IIN
Delisted

Intricon Stock News

etoro logo Buy IIN
*Your capital is at risk
$24.24
+0 (+0%)
At Close: Aug 23, 2022

IntriCon Corporation (IIN) Q4 Earnings and Revenues Surpass Estimates

03:05pm, Monday, 28'th Feb 2022 Zacks Investment Research
IntriCon Corporation (IIN) delivered earnings and revenue surprises of 2,200% and 6.18%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
IntriCon IIN +37%. NeuroSense Therapeutics (NRSN) +28%. Aurinia Pharmaceuticals AUPH -29%. Lexicon Pharmaceuticals LXRX -24%.

IntriCon to be acquired by Altaris Capital affiliate for $241M

02:01pm, Monday, 28'th Feb 2022 Seeking Alpha
Intricon (IIN) has entered into a definitive agreement whereby an affiliate of Altaris Capital Partners, an investment firm focused exclusively on the healthcare industry, will acquire…

Intricon Reports Fourth Quarter and Full Year 2021 Results

01:40pm, Monday, 28'th Feb 2022 GlobeNewswire Inc.
ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing

Intricon Reports Fourth Quarter and Full Year 2021 Results

01:40pm, Monday, 28'th Feb 2022 GlobeNewswire
ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN) , an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, today announced financial results for its fourth quarter and year ended December 31, 2021.
Intricon Shareholders to Receive $24.25 Per Share in Cash Intricon Shareholders to Receive $24.25 Per Share in Cash
Wilmington, Delaware--(Newsfile Corp. - February 28, 2022) - Rigrodsky Law, P.A. announces that it is investigating Intricon Corporation ("Intricon") (NASDAQ: IIN) regarding possible breaches of fiduc

Why Are Intricon Shares Surging Monday

01:20pm, Monday, 28'th Feb 2022
Altaris Capital Partners LLC will acquire Implantable device maker Intricon Corporation (NASDAQ: IIN) for $24.25 per share in a transaction that values Intricon at an equity value of approximately
MILWAUKEE, Feb. 28, 2022 /PRNewswire/ -- Ademi LLP is investigating Intricon (NASDAQ: IIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Altaris.  Click
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLP, an investor rights law firm, is investigating whether the sale of IntriCon Corporation (NASDAQ: IIN) to an affiliate of Altaris Capital Partners, LLC for $
ARDEN HILLS, Minn., Feb. 28, 2022 (GLOBE NEWSWIRE) -- Intricon Corporation (NASDAQ: IIN), an international joint development manufacturer engaged in designing, developing, engineering, manufacturing,
Intricon Shareholders to Receive $24.25 Per Share in Cash Intricon Shareholders to Receive $24.25 Per Share in Cash

Bandwidth (BAND) Surpasses Q4 Earnings and Revenue Estimates

11:45pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
Bandwidth (BAND) delivered earnings and revenue surprises of 164.29% and 6.92%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

TTDKY vs. IIN: Which Stock Is the Better Value Option?

04:40pm, Wednesday, 23'rd Feb 2022 Zacks Investment Research
TTDKY vs. IIN: Which Stock Is the Better Value Option?
TTDKY vs. IIN: Which Stock Is the Better Value Option?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE